Betsy Nabel, ModeX Therapeutics Inc.
Reflecting on the watershed events in health care of the past few years, Dean Lloyd Minor welcomes Betsy Nabel, the EVP for Strategy at ModeX Therapeutics and former President of Brigham and Women’s Hospital. They delve into lessons learned from the response to COVID-19 and examine what it takes to lead in public health during a once-in-a-generation crisis. Throughout their discussion, they examine core tenets of impactful leadership in health care, which can be applied in countless other sectors.
Meet Betsy Nabel
Executive Vice President for Strategy at ModeX Therapeutics Inc.
Elizabeth “Betsy” Nabel, MD, is Executive Vice President for Strategy at ModeX Therapeutics Inc., a biotech company focused on immunotherapies for cancer and infectious diseases. She is a Professor of Medicine Emerita at Harvard Medical School.
Prior to that, she served as President of Brigham Health and its Brigham and Women’s Hospital at Harvard Medical School. Dr. Nabel has held a variety of other leadership roles, including Director of the National Heart, Lung and Blood Institute at the National Institutes of Health, and Chief of Cardiology and Director of the Cardiovascular Research Institute at the University of Michigan. At the NHLBI, one of her signature advocacy efforts was the Red Dress Heart Truth campaign, which raises heart awareness in women through unprecedented industry partnerships.
An accomplished physician-scientist, Dr. Nabel’s work on the molecular genetics of cardiovascular diseases produced 17 patents, more than 250 scientific publications, and two start-up companies. Dr. Nabel is an elected member of the American Academy of the Arts and Sciences and the National Academy of Medicine. She serves on the boards of Medtronic, Moderna, Lyell, Accolade, and the Lasker Foundation.